Cold & Cough Remedies - Malaysia | Statista Market Forecast

In Malaysia, the revenue in the Cold & Cough Remedies market market in 2024 is estimated to be US$89.60m.
It is projected to experience an annual growth rate of 7.77% (CAGR 2024-2029).
When compared to other countries worldwide, the United States generates the highest revenue in this market, reaching US$11.19bn in 2024.
In terms of per capita figures, each individual in Malaysia generates revenues of US$2.58 in 2024.
In Malaysia, the demand for herbal cold and cough remedies is on the rise due to the country's traditional medicine practices.

Definition:
The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies market in Malaysia is experiencing significant growth due to various factors.

Customer preferences: Customers in Malaysia have shown a growing preference for over-the-counter cold and cough remedies. This can be attributed to the convenience and accessibility of these products, as well as the increasing awareness about self-care and the importance of managing common ailments at home. Additionally, the affordability of these remedies compared to prescription medications is also a driving factor for customer preference.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in Malaysia is the increasing demand for natural and herbal remedies. Customers are becoming more conscious about the ingredients used in the products they consume and are seeking alternatives to traditional pharmaceutical options. This trend is also influenced by the global shift towards natural and organic products.Another trend in the market is the growing popularity of combination cold and cough remedies. These products offer convenience to customers by addressing multiple symptoms with a single product. The demand for such combination remedies is driven by the desire for quick relief and ease of use.

Local special circumstances: Malaysia has a tropical climate, which makes it prone to certain weather-related health issues such as allergies and respiratory infections. This has created a specific need for cold and cough remedies in the market. Additionally, Malaysia has a large population and a growing middle class, which contributes to the overall demand for healthcare products, including cold and cough remedies.

Underlying macroeconomic factors: The growing economy in Malaysia has led to an increase in disposable income among consumers. This has resulted in higher healthcare spending and a willingness to invest in over-the-counter remedies for common ailments. Furthermore, the government's efforts to improve healthcare infrastructure and promote self-care have also contributed to the growth of the Cold & Cough Remedies market in Malaysia.In conclusion, the Cold & Cough Remedies market in Malaysia is witnessing growth due to customer preferences for over-the-counter remedies, the increasing demand for natural and herbal products, and the popularity of combination remedies. The local climate and population demographics also play a role in driving the market. Additionally, the growing economy and government initiatives have further fueled the market's expansion.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.